Search research articles
Contact Us
Filters
Showing results (21-30 of 174) with videos related to
Page
of 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2016
Measuring Toxicity in Phase I Clinical Trials--Letter
David M Hyman, Anne Eaton, S Percy Ivy, et al.
Gynecologic Oncology Reports
|
January 22, 2016
Primary debulking surgery for metastatic cervical adenocarcinoma: A case report
Sara M Davenport, Rudy S Suidan, James Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Learning All That We Can From MyPathway
Jessica J Tao, Alison M Schram, James J Harding, et al.
Clinical Nuclear Medicine
|
September 6, 2017
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Gary A Ulaner, David M Hyman, Serge K Lyashchenko, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 29, 2012
Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience
Rachel Nicole Grisham, Christina Adaniel, David M Hyman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 22, 2014
BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation
Olga L Bohn, Katharine Hsu, David M Hyman, et al.
Ocular Oncology and Pathology
|
June 9, 2020
MEK Inhibitor-Associated Central Retinal Vein Occlusion Associated with Hyperhomocysteinemia and MTHFR Variants
Jasmine H Francis, Eli L Diamond, Ping Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2012
The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials
Alexia Iasonos, Mrinal Gounder, David R Spriggs, et al.
JAMA Oncology
|
March 1, 2019
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program
Noah Z Feit, Debra A Goldman, Evan Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Reply to M. Voskoboynik et al
David M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 174) with videos related to
Sort By:
Page
of 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2016
Measuring Toxicity in Phase I Clinical Trials--Letter
David M Hyman, Anne Eaton, S Percy Ivy, et al.
Gynecologic Oncology Reports
|
January 22, 2016
Primary debulking surgery for metastatic cervical adenocarcinoma: A case report
Sara M Davenport, Rudy S Suidan, James Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2018
Learning All That We Can From MyPathway
Jessica J Tao, Alison M Schram, James J Harding, et al.
Clinical Nuclear Medicine
|
September 6, 2017
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Gary A Ulaner, David M Hyman, Serge K Lyashchenko, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 29, 2012
Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience
Rachel Nicole Grisham, Christina Adaniel, David M Hyman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 22, 2014
BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation
Olga L Bohn, Katharine Hsu, David M Hyman, et al.
Ocular Oncology and Pathology
|
June 9, 2020
MEK Inhibitor-Associated Central Retinal Vein Occlusion Associated with Hyperhomocysteinemia and MTHFR Variants
Jasmine H Francis, Eli L Diamond, Ping Chi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2012
The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials
Alexia Iasonos, Mrinal Gounder, David R Spriggs, et al.
JAMA Oncology
|
March 1, 2019
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program
Noah Z Feit, Debra A Goldman, Evan Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Reply to M. Voskoboynik et al
David M Hyman, Anne A Eaton, Mrinal M Gounder, et al.
Page
of 18